Radaelli, A. et al. Effects of slow, controlled breathing on baroreceptor control of heart rate and blood pressure in healthy men. J. Hypertension 22, 1361–1370 (2004).
Bernardi, L. et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 105, 143–145 (2002).
Harada, D. et al. Slow and deep respiration suppresses steady-state sympathetic nerve activity in patients with chronic heart failure: From modeling to clinical application. Am. J. Physiol. Heart Circ. Physiol. 307, H1159-1168 (2014).
Eckberg, D. L. & Orshan, C. R. Respiratory and baroreceptor reflex interactions in man. J. Clin. Invest. 59, 780–785 (1977).
Mortara, A. et al. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 96, 3450–3458 (1997).
Ferguson, D. W., Berg, W. J., Roach, P. J., Oren, R. M. & Mark, A. L. Effects of heart failure on baroreflex control of sympathetic neural activity. Am. J. Cardiol. 69, 523–531 (1992).
Eckberg, D. L. & Sleight, P. Human Baroreflexes in Health and Disease (Clarendon Press, 1992).
Schultz, H. D., Marcus, N. J. & Del Rio, R. Mechanisms of carotid body chemoreflex dysfunction during heart failure. Exp. Physiol. 100, 124–129 (2015).
Ding, Y., Li, Y.-L. & Schultz, H. D. Role of blood flow in carotid body chemoreflex function in heart failure. J. Physiol. 589, 245–258 (2011).
Somers, V. K., Mark, A. L. & Abboud, F. M. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J. Clin. Invest. 87, 1953–1957 (1991).
Francis, D. P., Coats, A. J. & Ponikowski, P. Chemoreflex–baroreflex interactions in cardiovascular disease. In Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease 33–60 (Dekker, 2000).
Anand, I. S. et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107, 1278–1283 (2003).
Galasko, G. I. W., Lahiri, A., Barnes, S. C., Collinson, P. & Senior, R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur. Heart J. 26, 2269–2276 (2005).
Tang, W. H. W. et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116, e99-109 (2007).
Duffty, P., Spriet, L., Bryan, M. H. & Bryan, A. C. Respiratory induction plethysmography (Respitrace): An evaluation of its use in the infant. Am. Rev. Respir. Dis. 123, 542–546 (1981).
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 17, 354–381 (1996).
Di Rienzo, M., Castiglioni, P., Parati, G., Mancia, G. & Pedotti, A. Effects of sino-aortic denervation on spectral characteristics of blood pressure and pulse interval variability: A wide-band approach. Med. Biol. Eng. Comput. 34, 133–141 (1996).
Robbe, H. W. et al. Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10, 538–543 (1987).
Castiglioni, P. et al. Broad-band spectral analysis of 24 h continuous finger blood pressure: Comparison with intra-arterial recordings. Clin. Sci. 97, 129–139 (1999).
Jenkins, G. M. & Watts, D. G. Spectral Analysis and Its Applications (Holden-Day, 1968).
Radaelli, A., Mancia, G., De Carlini, C., Soriano, F. & Castiglioni, P. Patterns of cardiovascular variability after long-term sino-aortic denervation in unanesthetized adult rats. Sci. Rep. 9, 25 (2019).
Modarreszadeh, M. & Bruce, E. N. Ventilatory variability induced by spontaneous variations of PaCO2 in humans. J. Appl. Physiol. 1985(76), 2765–2775 (1994).
Lahiri, S., Hsiao, C., Zhang, R., Mokashi, A. & Nishino, T. Peripheral chemoreceptors in respiratory oscillations. J. Appl. Physiol. 1985(58), 1901–1908 (1985).
Khoo, M. C., Kronauer, R. E., Strohl, K. P. & Slutsky, A. S. Factors inducing periodic breathing in humans: A general model. J. Appl. Physiol. 53, 644–659 (1982).
Dempsey, J. A. & Smith, C. A. Pathophysiology of human ventilatory control. Eur. Respir. J. 44, 495–512 (2014).
Cohn, J. N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819–823 (1984).
Cao, J. J., Li, L., McLaughlin, J. & Passick, M. Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging. Eur. Heart J. Cardiovasc. Imaging 19, 339–346 (2018).
Bilo, G. et al. Effects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamics. PLoS One 7, e49074 (2012).
Bernardi, L. et al. Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure. Lancet 351, 1308–1311 (1998).
Cross, T. J., Kim, C.-H., Johnson, B. D. & Lalande, S. The interactions between respiratory and cardiovascular systems in systolic heart failure. J. Appl. Physiol. 1985(128), 214–224 (2020).
La Rovere, M. T. et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J. Am. Coll. Cardiol. 53, 193–199 (2009).
Bibevski, S. & Dunlap, M. E. Evidence for impaired vagus nerve activity in heart failure. Heart Fail. Rev. 16, 129–135 (2011).
Hartmann, F. et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial. Circulation 110, 1780–1786 (2004).
Spinar, J. et al. Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction—a report from FAR NHL prospective registry. PLoS One 14, e0214363 (2019).
Grassi, G. et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96, 1173–1179 (1997).
Shepherd, J. T. The lungs as receptor sites for cardiovascular regulation. Circulation 63, 1–10 (1981).
Bernardi, L., Gabutti, A., Porta, C. & Spicuzza, L. Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J. Hypertens. 19, 2221–2229 (2001).
Taylor, J. A., Carr, D. L., Myers, C. W. & Eckberg, D. L. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 98, 547–555 (1998).
La Rovere, M. T. et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 103, 2072–2077 (2001).
van de Borne, P., Montano, N., Pagani, M., Oren, R. & Somers, V. K. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95, 1449–1454 (1997).
Grassi, G. et al. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 26, 348–354 (1995).
Goso, Y. et al. Respiratory modulation of muscle sympathetic nerve activity in patients with chronic heart failure. Circulation 104, 418–423 (2001).
Guyenet, P. G., Koshiya, N., Huangfu, D., Verberne, A. J. & Riley, T. A. Central respiratory control of A5 and A6 pontine noradrenergic neurons. Am. J. Physiol. 264, R1035-1044 (1993).
Eckberg, D. L. Point:counterpoint: Respiratory sinus arrhythmia is due to a central mechanism vs respiratory sinus arrhythmia is due to the baroreflex mechanism. J. Appl. Physiol. (1985) 106, 1740–1742 (2009).
Hayano, J., Yasuma, F., Okada, A., Mukai, S. & Fujinami, T. Respiratory sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory efficiency. Circulation 94, 842–847 (1996).
Ito, S. et al. Vagal nerve activity contributes to improve the efficiency of pulmonary gas exchange in hypoxic humans. Exp. Physiol. 91, 935–941 (2006).
Ben-Tal, A., Wang, Y. & Leite, M. C. A. The logic behind neural control of breathing pattern. Sci. Rep. 9, 9078 (2019).
Van den Aardweg, J. G. & Karemaker, J. M. Influence of chemoreflexes on respiratory variability in healthy subjects. Am. J. Respir. Crit. Care Med. 165, 1041–1047 (2002).
Toledo, C. et al. Contribution of peripheral and central chemoreceptors to sympatho-excitation in heart failure. J. Physiol. 595, 43–51 (2017).
Ponikowski, P. et al. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: Clinical implications and role of augmented peripheral chemosensitivity. Circulation 100, 2418–2424 (1999).
Porta, A. et al. Model-based assessment of baroreflex and cardiopulmonary couplings during graded head-up tilt. Comput. Biol. Med. 42, 298–305 (2012).
Parati, G. et al. Closed-loop cardiovascular interactions and the baroreflex cardiac arm: Modulations over the 24 hours and the effect of hypertension. Front. Physiol. 10, 1–10 (2019).
